Bystander Effect Contributes to the Antitumor Efficacy of CaSm Antisense Gene Therapy in a Preclinical Model of Advanced Pancreatic Cancer
Open Access
- 28 February 2006
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 13 (2) , 357-365
- https://doi.org/10.1016/j.ymthe.2005.06.485
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Establishing a Murine Pancreatic Cancer CaSm Model: Up-regulation of CaSm Is Required for the Transformed Phenotype of Murine Pancreatic AdenocarcinomaMolecular Therapy, 2005
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expressionCancer Gene Therapy, 2003
- A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancerGene Therapy, 2002
- Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasisCancer Gene Therapy, 2001
- Connexin-Independent Ganciclovir-Mediated Killing Conferred on Bystander Effect-Resistant Cell Lines by a Herpes Simplex Virus–Thymidine Kinase-Expressing Colon Cell LineMolecular Therapy, 2000
- Yeast Sm-like proteins function in mRNA decapping and decayNature, 2000
- Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanismsCancer Gene Therapy, 2000
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998